Lobbying client

ICHOR SCIENCES

Produce hemostatic devices to stop bleeding in non-compressible wounds

Filings
5
Filed by
1
Reported in-house
—
Reported by firms
$55,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2022 to 2023

Filings

5 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2023
STRATEGIC MARKETING INNOVATIONS $5,000 reported
2nd Quarter - Report
2nd Quarter 2023
STRATEGIC MARKETING INNOVATIONS $20,000 reported
1st Quarter - Report
1st Quarter 2023
STRATEGIC MARKETING INNOVATIONS $20,000 reported
4th Quarter - Report
4th Quarter 2022
STRATEGIC MARKETING INNOVATIONS $10,000 reported
Registration
4th Quarter 2022
STRATEGIC MARKETING INNOVATIONS — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
STRATEGIC MARKETING INNOVATIONS 4 $55,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Medical/Disease Research/Clinical Labs MED 5

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.